Some notes:
Cu64-67 is a “bio-identical” pair. Does that mean the safety and efficacy of Cu64 will most likely be replicated in Cu67?4:20 “We have seen this response not just in one but a number of patients”5:30 “Moving to cohort 4 in summer. Patients are being pre-vetted right now”10- “30% of the patients have had a very good response not necessarily at the level of the first patient who data was presented. But that is still at the 8GBq and not at the 12GBq!”
Some notes:Cu64-67 is a “bio-identical” pair. Does that mean the...
-
- There are more pages in this discussion • 183 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.23 |
Change
0.360(5.24%) |
Mkt cap ! $2.282B | |||
| Open | High | Low | Value | Volume |
| $7.05 | $7.27 | $6.86 | $9.068M | 1.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2748 | $7.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.24 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |